Literature DB >> 9125546

Role of interleukin-10 in regulation of T-cell-dependent and T-cell-independent mechanisms of resistance to Toxoplasma gondii.

L E Neyer1, G Grunig, M Fort, J S Remington, D Rennick, C A Hunter.   

Abstract

Interleukin-10 (IL-10) is a cytokine which can inhibit T-cell and natural killer (NK) cell functions associated with cell-mediated immunity to intracellular infections. The production of IL-10 by mice infected with Toxoplasma gondii has been implicated in the suppression of lymphocyte proliferation observed during acute toxoplasmosis, as well as susceptibility to infection with this parasite. We have used C57BL/6 mice which lack a functional IL-10 gene (IL-10(-/-) mice) to investigate the role of IL-10 in acute toxoplasmosis. Intraperitoneal infection of IL-10(-/-) mice with T. gondii resulted in 100% mortality by day 13, whereas wild-type C57BL/6 (WT) mice survived acute infection. IL-10(-/-) mice infected with T. gondii had significantly higher serum levels of IL-12 and gamma interferon (IFN-gamma) than WT mice. Early mortality of infected IL-10(-/-) mice was prevented by treatment with IL-10 and significantly delayed by neutralizing antibodies to IL-12 and IFN-gamma. Further studies revealed that SCID/IL-10(-/-) mice infected with T. gondii had delayed time to death compared to IL-10(-/-) mice, indicating that lymphocytes contributed to death of IL-10(-/-) mice. In addition, infected SCID/IL-10(-/-) mice survived longer than infected SCID mice. These latter data indicate that in mice lacking lymphocytes, endogenous IL-10 is associated with increased susceptibility to T. gondii. However, the lack of IL-10 does not alter the infection-induced suppression of T cell and NK cell functions. Our experiments reveal that IL-10 is associated with protection or increased susceptibility to infection with T. gondii, depending on whether mice possess lymphocytes, and demonstrate the important roles of IL-12 and IFN-gamma in the early infection-induced mortality observed in the IL-10(-/-) mice.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9125546      PMCID: PMC175195          DOI: 10.1128/iai.65.5.1675-1682.1997

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  45 in total

1.  IL-10 inhibits parasite killing and nitrogen oxide production by IFN-gamma-activated macrophages.

Authors:  R T Gazzinelli; I P Oswald; S L James; A Sher
Journal:  J Immunol       Date:  1992-03-15       Impact factor: 5.422

2.  Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses.

Authors:  D J Berg; N Davidson; R Kühn; W Müller; S Menon; G Holland; L Thompson-Snipes; M W Leach; D Rennick
Journal:  J Clin Invest       Date:  1996-08-15       Impact factor: 14.808

3.  Production of interferon gamma, interleukin 2, interleukin 4, and interleukin 10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis.

Authors:  F P Heinzel; M D Sadick; S S Mutha; R M Locksley
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

4.  Mucosal and systemic cellular immune responses induced by Toxoplasma gondii antigens in cyst orally infected mice.

Authors:  T Chardès; F Velge-Roussel; P Mevelec; M N Mevelec; D Buzoni-Gatel; D Bout
Journal:  Immunology       Date:  1993-03       Impact factor: 7.397

5.  Demonstration of T-cell dysfunction during acute toxoplasma infection.

Authors:  J Chan; J P Siegel; B J Luft
Journal:  Cell Immunol       Date:  1986-04-01       Impact factor: 4.868

6.  SCID mouse models of acute and relapsing chronic Toxoplasma gondii infections.

Authors:  L L Johnson
Journal:  Infect Immun       Date:  1992-09       Impact factor: 3.441

Review 7.  Interleukin-10.

Authors:  R de Waal Malefyt; H Yssel; M G Roncarolo; H Spits; J E de Vries
Journal:  Curr Opin Immunol       Date:  1992-06       Impact factor: 7.486

8.  Interferon-gamma: the major mediator of resistance against Toxoplasma gondii.

Authors:  Y Suzuki; M A Orellana; R D Schreiber; J S Remington
Journal:  Science       Date:  1988-04-22       Impact factor: 47.728

9.  Interleukin 10 and interferon gamma regulation of experimental Trypanosoma cruzi infection.

Authors:  J S Silva; P J Morrissey; K H Grabstein; K M Mohler; D Anderson; S G Reed
Journal:  J Exp Med       Date:  1992-01-01       Impact factor: 14.307

10.  Human lymphokine-activated killer cells are cytotoxic against cells infected with Toxoplasma gondii.

Authors:  C S Subauste; L Dawson; J S Remington
Journal:  J Exp Med       Date:  1992-12-01       Impact factor: 14.307

View more
  50 in total

1.  Transforming growth factor beta1 is expressed in the jejunum after experimental Cryptosporidium parvum infection in humans.

Authors:  P Robinson; P C Okhuysen; C L Chappell; D E Lewis; I Shahab; S Lahoti; A C White
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

2.  Neutrophil depletion during Toxoplasma gondii infection leads to impaired immunity and lethal systemic pathology.

Authors:  S K Bliss; L C Gavrilescu; A Alcaraz; E Y Denkers
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

Review 3.  Costimulation in resistance to infection and development of immune pathology: lessons from toxoplasma.

Authors:  Christopher A Hunter; Linda A Lieberman; Nicola Mason; Marion Pepper; Sarah L Sague; Cristina Tato; Valerie Zediak
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

4.  An unusual pro-inflammatory role of interleukin-10 induced by arabinosylated lipoarabinomannan in murine peritoneal macrophages.

Authors:  Nivedita Majumder; Ranadhir Dey; Ram Kumar Mathur; Sriparna Datta; Madhumita Maitra; Sanjukta Ghosh; Bhaskar Saha; Subrata Majumdar
Journal:  Glycoconj J       Date:  2006-12       Impact factor: 2.916

5.  IL-1R Regulates Disease Tolerance and Cachexia in Toxoplasma gondii Infection.

Authors:  Stephanie J Melchor; Claire M Saunders; Imani Sanders; Jessica A Hatter; Kari A Byrnes; Sheryl Coutermarsh-Ott; Sarah E Ewald
Journal:  J Immunol       Date:  2020-04-29       Impact factor: 5.422

6.  Toxoplasma gondii regulates recruitment and migration of human dendritic cells via different soluble secreted factors.

Authors:  J Diana; C Vincent; F Peyron; S Picot; D Schmitt; F Persat
Journal:  Clin Exp Immunol       Date:  2005-09       Impact factor: 4.330

Review 7.  Subversion of innate and adaptive immune responses by Toxoplasma gondii.

Authors:  Christine Lang; Uwe Gross; Carsten G K Lüder
Journal:  Parasitol Res       Date:  2006-10-06       Impact factor: 2.289

Review 8.  Understanding the multiple functions of Gr-1(+) cell subpopulations during microbial infection.

Authors:  Charlotte E Egan; Woraporn Sukhumavasi; Allison L Bierly; Eric Y Denkers
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

Review 9.  The molecular biology and immune control of chronic Toxoplasma gondii infection.

Authors:  Xiao-Yu Zhao; Sarah E Ewald
Journal:  J Clin Invest       Date:  2020-07-01       Impact factor: 14.808

10.  Protective role for interleukin-5 during chronic Toxoplasma gondii infection.

Authors:  Y Zhang; E Y Denkers
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.